Use of growth hormone in non-growth hormone deficient children

Ajay Sood, P. S N Menon

Research output: Contribution to journalReview article

Abstract

The easy availability of growth hormone (GH) in the Indian market has led to its increased use in the management of short stature. However, the therapy is expensive for most families. The possible benefits of such a therapy have to be carefully weighed against the cost and adverse effects. We discuss the drawbacks of relying on data based on predicted height to evaluate the benefits of GH therapy reported in the literature. It is the final adult height which is the true indicator of the efficacy of GH therapy. The only clear indications for GH therapy are short stature associated with GH deficiency and Turner syndrome. Classifying short stature may not be of much help in deciding the utility of GH therapy and the use of auxological criteria alone will increase the burden on society. At present, the use of GH in idiopathic short stature is not indicated in routine clinical practice.

Original languageEnglish (US)
Pages (from-to)222-225
Number of pages4
JournalNational Medical Journal of India
Volume11
Issue number5
StatePublished - Sep 1 1998
Externally publishedYes

Fingerprint

Growth Hormone
Hormones
Therapeutics
Turner Syndrome
Costs and Cost Analysis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Use of growth hormone in non-growth hormone deficient children. / Sood, Ajay; Menon, P. S N.

In: National Medical Journal of India, Vol. 11, No. 5, 01.09.1998, p. 222-225.

Research output: Contribution to journalReview article

@article{d91d73b252c44b658947dad5e2f646fb,
title = "Use of growth hormone in non-growth hormone deficient children",
abstract = "The easy availability of growth hormone (GH) in the Indian market has led to its increased use in the management of short stature. However, the therapy is expensive for most families. The possible benefits of such a therapy have to be carefully weighed against the cost and adverse effects. We discuss the drawbacks of relying on data based on predicted height to evaluate the benefits of GH therapy reported in the literature. It is the final adult height which is the true indicator of the efficacy of GH therapy. The only clear indications for GH therapy are short stature associated with GH deficiency and Turner syndrome. Classifying short stature may not be of much help in deciding the utility of GH therapy and the use of auxological criteria alone will increase the burden on society. At present, the use of GH in idiopathic short stature is not indicated in routine clinical practice.",
author = "Ajay Sood and Menon, {P. S N}",
year = "1998",
month = "9",
day = "1",
language = "English (US)",
volume = "11",
pages = "222--225",
journal = "National Medical Journal of India",
issn = "0970-258X",
publisher = "All India Institute of Medical Sciences",
number = "5",

}

TY - JOUR

T1 - Use of growth hormone in non-growth hormone deficient children

AU - Sood, Ajay

AU - Menon, P. S N

PY - 1998/9/1

Y1 - 1998/9/1

N2 - The easy availability of growth hormone (GH) in the Indian market has led to its increased use in the management of short stature. However, the therapy is expensive for most families. The possible benefits of such a therapy have to be carefully weighed against the cost and adverse effects. We discuss the drawbacks of relying on data based on predicted height to evaluate the benefits of GH therapy reported in the literature. It is the final adult height which is the true indicator of the efficacy of GH therapy. The only clear indications for GH therapy are short stature associated with GH deficiency and Turner syndrome. Classifying short stature may not be of much help in deciding the utility of GH therapy and the use of auxological criteria alone will increase the burden on society. At present, the use of GH in idiopathic short stature is not indicated in routine clinical practice.

AB - The easy availability of growth hormone (GH) in the Indian market has led to its increased use in the management of short stature. However, the therapy is expensive for most families. The possible benefits of such a therapy have to be carefully weighed against the cost and adverse effects. We discuss the drawbacks of relying on data based on predicted height to evaluate the benefits of GH therapy reported in the literature. It is the final adult height which is the true indicator of the efficacy of GH therapy. The only clear indications for GH therapy are short stature associated with GH deficiency and Turner syndrome. Classifying short stature may not be of much help in deciding the utility of GH therapy and the use of auxological criteria alone will increase the burden on society. At present, the use of GH in idiopathic short stature is not indicated in routine clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=0032148714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032148714&partnerID=8YFLogxK

M3 - Review article

C2 - 10997170

AN - SCOPUS:0032148714

VL - 11

SP - 222

EP - 225

JO - National Medical Journal of India

JF - National Medical Journal of India

SN - 0970-258X

IS - 5

ER -